Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy

Prostate Cancer and Prostatic Diseases

Volumn 12, Issue 2, 2009, Pages 204-208

  Sankin, A ^a   Tareen, B ^a   Lepor, H ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE ANTIGEN;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RADICAL RETROPUBIC PROSTATECTOMY; SEMINAL VESICLE; TRANSRECTAL ULTRASONOGRAPHY; TUMOR VOLUME;

ADENOCARCINOMA; AGE FACTORS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS; SEMINAL VESICLES;

EID: 67349241950     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2009.2     Document Type: Article

References (20)

1. Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW, Epstein JI et al The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993; 150: 110.
2. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969.
3. Makarov DV, Trock BJ, Humphreys EB, Mangold LA, Walsh PC, Epstein JI et al. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology 2007; 69: 1095.
4. May M, Knoll N, Siegsmund M, Fahlenkamp D, Vogler H, Hoschke B et al Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients. J Urol 2007; 178: 1957.
5. Catalona WJ, Basler JW. Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J Urol 1993; 150: 905.
6. Lepor H, Walsh PC. Long-term results of radical prostatectomy in clinically localized prostate cancer: Experience at the Johns Hopkins Hospital. NCI Monogr 1988; 7: 117b.
7. Talcott JA, Rieker P, Propert KJ, Clark JA, Wishnow KI, Loughlin KR et al. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst 1997; 89: 1117.
8. Bellina M, Mari M, Ambu A, Guercio S, Rolle L, Tampellini M. Seminal monolateral nerve-sparing radical prostatectomy in selected patients. Urol Int 2005; 75: 175.
9. Poissonnier L, Chapelon JY, Rouviere O, Curiel L, Bouvier R, Martin X et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 2007; 51: 381.
10. Blana A, Murat FJ, Walter B, Thuroff S, Wieland WF, Chaussy C et al First Analysis of the Long-Term Results with Transrectal HIFU in Patients with Localised Prostate Cancer. Eur Urol 2008; 53: 1194-1201.
11. Polascik TJ, Nosnik I, Mayes JM, Mouraviev V. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology. Urol 2007; 70: 117-121.
12. Taneja SS, Penson DF, Epelbaum A, Handler T, Lepor H. Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen. J Urol 1999; 162: 1352.
13. Walsh PC, Lepor H, Eggleston JC. Radical prostatectomy with preservation of sexual function: Anatomical and pathological considerations. Prostate 1983; 4: 473.
14. Bostwick DG, Foster CS. Pathology of the Prostate. Philadelphia: W.B. Saunders Co., p.172, 1998.
15. Egan AJ, Bostwick DG. Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: Perineural invasion lacks significance on multivariate analysis. Am J Surg Pathol 1997; 21: 1496.
16. Bostwick DG, Qian J, Bergstralh E, Dundore P, Dugan J, Myers RP et al Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. J Urol 1996; 155: 1361.
17. Hassan MO, Maksem J. The prostatic perineural space and its relation to tumor spread: An ultrastructural study. Am J Surg Pathol 1980; 4: 143.
18. Freedland SJ, IsaacsWB, Platz EA, Terris MK, Aronson WJ, Amling CL et al. Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: A search database study. J Clin Oncol 2005; 23: 7546.
19. Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994; 271: 368.
20. Ohori M, Kattan MW, Koh H, Maru N, Slawin KM, Shariat S et al. Predicting the presence and side of extracapsular extension: A nomogram for staging prostate cancer. J Urol 2004; 171: 1844.